Elaine Sun

Elaine Sun is currently the CFO & Chief Operating Officer at Mammoth Biosciences. Prior to this, they were the SVP and Chief Financial Officer at Halozyme Therapeutics, Inc. from March 2020 to February 2022. From December 2018 to May 2021, they served as a Board Member at Cirius Therapeutics. From January 2017 to December 2019, they were the CFO & Chief Strategy Officer at SutroVax Inc., a biopharmaceutical company dedicated to developing best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent deadly infectious diseases. From January 2013 to December 2016, they were a Strategic and Financial Advisory Consultant. Prior to that, they were a Managing Director at Evercore Partners from November 2009 to December 2012. Her previous role was as Managing Director at Merrill Lynch from January 1996 to December 2008.

Elaine Sun has a Master of Business Administration (MBA) from Harvard Business School and a Bachelor of Arts (B.A.) in Economics and Japanese Studies from Wellesley College.

Kathy Perry - Director of Quality, Scott Bradley - Director, Supply Chain report to Elaine Sun. Elaine Sun reports to Trevor Martin, Co-founder & CEO. Some of their coworkers include Jenny Speer - Director of People, Janice Chen - Co-founder & CTO, and Kevin Grossenbacher - Director of Project Management.